Comment on "A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 Patients" by Kahramangil B et al
- PMID: 33914489
- DOI: 10.1097/SLA.0000000000004804
Comment on "A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 Patients" by Kahramangil B et al
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Response to the Comment on "A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 Patients" by Kahramangil B et al.Ann Surg. 2021 Dec 1;274(6):e888-e889. doi: 10.1097/SLA.0000000000004792. Ann Surg. 2021. PMID: 33605590 No abstract available.
Comment on
-
A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 Patients.Ann Surg. 2022 Jan 1;275(1):e238-e244. doi: 10.1097/SLA.0000000000004048. Ann Surg. 2022. PMID: 32541223
References
-
- Kahramangil B, Kose E, Remer EM, et al. A modern assessment of cancer risk in adrenal incidentalomas: analysis of 2219 patients. Ann Surg 2020; doi: 10.1097/SLA.0000000000004048. Online ahead of print. - DOI
-
- Bancos I, Taylor AE, Chortis V, et al. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Lancet Diabetes Endocrinol 2020; 8:773–781.
-
- Palazzo F, Dickinson A, Phillips B, et al. Adrenal surgery in England: better outcomes in high-volume practices. Clin Endocrinol (Oxf) 2016; 85:17–20.
-
- Park HS, Roman SA, Sosa JA. Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty? Arch Surg 2009; 144:1060–1067.
-
- Arlt W, Biehl M, Taylor AE, et al. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 2011; 96:3775–3784.
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical